Cargando…
Comparative evaluation of the pain-relieving properties of a lecithinized formulation of curcumin (Meriva(®)), nimesulide, and acetaminophen
In addition to its anti-inflammatory activity, Meriva(®), a proprietary lecithin formulation of curcumin, has been anecdotally reported to decrease acute pain in patients with various chronic diseases. Given that curcumin can desensitize transient receptor potential A1, a nociceptor seemingly also m...
Autores principales: | Francesco, Di Pierro, Giuliana, Rapacioli, Eleonora, Adriana Di Maio, Giovanni, Appendino, Federico, Franceschi, Stefano, Togni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596124/ https://www.ncbi.nlm.nih.gov/pubmed/23526055 http://dx.doi.org/10.2147/JPR.S42184 |
Ejemplares similares
-
Reduction of delayed onset muscle soreness by a novel curcumin delivery system (Meriva®): a randomised, placebo-controlled trial
por: Drobnic, Franchek, et al.
Publicado: (2014) -
Curcumin Supplementation (Meriva(®)) Modulates Inflammation, Lipid Peroxidation and Gut Microbiota Composition in Chronic Kidney Disease
por: Pivari, Francesca, et al.
Publicado: (2022) -
Oral Curcumin (Meriva) Is Effective as an Adjuvant Treatment and Is Able to Reduce IL-22 Serum Levels in Patients with Psoriasis Vulgaris
por: Antiga, Emiliano, et al.
Publicado: (2015) -
Development of in vitro - in vivo correlations for newly optimized Nimesulide formulations
por: Hanif, Muhammad, et al.
Publicado: (2018) -
Lallemantia reylenne seeds as superdisintegrant: Formulation and evaluation of nimesulide orodispersible tablets
por: Malik, Karan, et al.
Publicado: (2011)